Declor SR 6mg Tablet

Introduction

Declor SR is a prescription medication that contains the active ingredient Dexchlorpheniramine. Dexchlorpheniramine is an antihistamine that is commonly used to relieve symptoms associated with allergies, such as sneezing, itching, watery eyes, and runny nose.

Uses

Declor SR is primarily prescribed for the treatment of allergic conditions, including hay fever (allergic rhinitis) and allergic skin reactions (hives or urticaria). It can also be used to manage symptoms of the common cold and other respiratory allergies.

Dosage and Administration

The recommended dosage of Declor SR may vary depending on the individual’s age, medical condition, and response to treatment. Follow the instructions provided by your healthcare professional. Typically, the usual adult dose is 1 tablet (4 mg) taken every 4 to 6 hours, with a maximum daily dose of 12 mg. For children, the dosage is usually based on their age and weight.

Declor SR should be taken orally with or without food, as directed by your healthcare professional. Swallow the tablet whole and not crush or chew it, unless otherwise advised by your doctor.

Mechanism of Action

Dexchlorpheniramine, the active ingredient in Declor SR, works by blocking the action of histamine, a substance in the body that causes allergic symptoms. By blocking histamine, Dexchlorpheniramine helps to alleviate symptoms such as itching, sneezing, and runny nose.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, and constipation. These side effects are usually mild and temporary.

In rare cases, serious side effects may occur. If you experience any of the following symptoms, seek immediate medical attention: rapid or irregular heartbeat, difficulty urinating, severe dizziness, mental/mood changes, or seizures.

Drug Interactions

Declor SR may interact with other medications, including certain antidepressants, sedatives, tranquilizers, and antihistamines. These interactions can increase the risk of side effects or reduce the effectiveness of either medication. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements.

Precautions

Before taking Declor SR, inform your healthcare professional if you have any allergies, medical conditions, or if you are pregnant or breastfeeding. This medication may not be suitable for everyone, and your healthcare professional will consider these factors before prescribing it.

Declor SR should be used with caution in individuals with certain medical conditions, such as glaucoma, asthma, urinary retention, or an enlarged prostate. Follow your healthcare professional’s advice and recommendations.

Storage

Patient Tips

• Take Declor SR exactly as prescribed by your healthcare professional. Do not exceed the recommended dosage or use it for longer than recommended.
• If you experience drowsiness or dizziness while taking this medication, avoid activities that require alertness, such as driving or operating machinery.
• Avoid consuming alcohol or other sedating substances while taking Declor SR, as it may increase the risk of drowsiness and other side effects.
• If you have any concerns or questions about your treatment, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Dexchlorpheniramine (Drugs.com) [Accessed 0 Jun. 2024] (online) Available at:
• dexchlorpheniramine 1 mg-chlophedianol 12.5 mg/5 ml oral liquid (OTC) [Accessed 24 Jun. 2024] (online) Available at:
• Pheniramine overdose (MedlinePlus) [Accessed 18 Jun. 2024] (online) Available at:
• [No authors listed] Dexchlorpheniramine. 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 30 Jun. 2024] Available at: